|
1.
|
Siegel R, Naishadham D and Jemal A: Cancer
statistics, 2012. CA Cancer J Clin. 62:10–29. 2012. View Article : Google Scholar
|
|
2.
|
McErlean A and Ginsberg MS: Epidemiology
of lung cancer. Semin Roentgenol. 46:173–177. 2011. View Article : Google Scholar
|
|
3.
|
Jemal A, Siegel R, Ward E, Murray T, Xu J,
Smigal C and Tun MJ: Cancer statistics. CA Cancer J Clin.
56:106–130. 2006.
|
|
4.
|
Hsu HF, Huang KH, Lu KJ, Chiou SJ, Yen JH,
Chang CC and Houng JY: Typhonium blumei extract inhibits
proliferation of human lung adenocarcinoma A549 cells via induction
of cell cycle arrest and apoptosis. J Ethnopharmacol. 135:492–500.
2011. View Article : Google Scholar
|
|
5.
|
Xu X, Zhang Y, Qu D, Jiang T and Li S:
Osthole induces G2/M arrest and apoptosis in lung cancer A549 cells
by modulating PI3K/Akt pathway. J Exp Clin Cancer Res. 30:332011.
View Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Wilkinson RW, Odedra R, Heaton SP, Wedge
SR, Keen NJ, Crafter C, Foster JR, Brady MC, Bigley A, Brown E,
Byth KF, Barrass NC, Mundt KE, Foote KM, Heron NM, Jung FH,
Mortlock AA, Boyle FT and Green S: AZD1152, a selective inhibitor
of Aurora B kinase, inhibits human tumor xenograft growth by
inducing apoptosis. Clin Cancer Res. 13:3682–3688. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Harada T, Yatabe Y, Takeshita M, Koga T,
Yano T, Wang Y and Giaccone G: Role and relevance of TrkB mutations
and expression in non-small cell lung cancer. Clin Cancer Res.
9:2638–2645. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Yilmaz T, Jiffar T, Garza G, Lin H, Milas
Z, Takahashi Y, Hanna E, MacIntyre T, Brown JL, Myers JN, Kupferman
ME and Michael E: Theraputic targeting of Trk supresses tumor
proliferation and enhances cisplatin activity in HNSCC. Cancer Biol
Ther. 10:644–653. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9.
|
Brodeur GM, Minturn JE, Ho R, Simpson AM,
Iyer R, Varela CR, Light JE, Kolla V and Evans AE: Trk receptor
expression and inhibition in neuroblastomas. Clin Cancer Res.
10:3244–3250. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10.
|
Koizumi H, Morita M, Mikami S, Shibayama E
and Uchikoshi T: Immunohistochemical analysis of TrkA neurotrophin
receptor expression in human non-neuronal carcinomas. Pathol Int.
2:93–101. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Thress K, Macintyre T, Wang H, Whitston D,
Liu ZY, Hoffmann E, Wang T, Brown JL, Webster K, Omer C, Zage PE,
Zeng L and Zweidler-McKay PA: Identification and preclinical
characterization of AZ-23, a novel, selective, and orally
bioavailable inhibitor of the Trk kinase pathway. Mol Cancer Ther.
7:1818–1827. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Iyer R, Varela CR, Minturn JE, Ho R,
Simpson AM, Light JE, Evans AE, Zhao H, Thress K, Brown JL and
Brodeur GM: AZ64 inhibits TrkB and enhances the efficacy of
chemotherapy and local radiation in neuroblastoma xenografts.
Cancer Chemother Pharmacol. May 24–2012.(Epub ahead of print).
|
|
13.
|
Castedo M, Perfettini JL, Roumier T and
Kroemer G: Cyclin-dependent kinase-1: linking apoptosis to cell
cycle and mitotic catastrophe. Cell Death Differ. 9:1287–1293.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Lindqvist A, Rodríguez-Bravo V and Medema
RH: The decision to enter mitosis: feedback and redundancy in the
mitotic entry network. J Cell Biol. 185:193–202. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Telles E, Gurjar M, Ganti K, Gupta D and
Dalal SN: Filamin A stimulates Cdc25C function and promotes entry
into mitosis. Cell Cycle. 10:776–782. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Peng CY, Graves PR, Thoma RS, Wu Z, Shaw
AS and Piwnica-Worms H: Mitotic and G2 checkpoint control:
regulation of 14-3-3 protein binding by phosphorylation of Cdc25C
on serine-216. Science. 277:1501–1505. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Toyoshima-Morimoto F, Taniguchi E and
Nishida E: Plk1 promotes nuclear translocation of human Cdc25C
during prophase. EMBO Rep. 4:341–348. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Seki A, Coppinger JA, Jang CY, Yates JR
and Fang G: Bora and the kinase Aurora A cooperatively activate the
kinase Plk1 and control mitotic entry. Science. 20:1655–1658. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Choi HJ, Fukui M and Zhu BT: Role of
cyclin B1/Cdc2 up-regulation in the development of mitotic
prometaphase arrest in human breast cancer cells treated with
nocodazole. PLoS One. 6:e243122011. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Wang ZX, Xue D, Liu ZL, Lu BB, Bian HB,
Pan X and Yin YM: Overexpression of polo-like kinase 1 and its
clinical significance in human non-small cell lung cancer. Int J
Biochem Cell Biol. 44:200–210. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Lens SM, Voest EE and Medema RH: Shared
and separate functions of polo-like kinases and aurora kinases in
cancer. Nat Rev Cancer. 10:825–841. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Chang DC, Xu N and Luo KQ: Degradation of
cyclin B is required for the onset of anaphase in mammalian cells.
J Biol Chem. 278:37865–37873. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Jorgensen TJ, Tian H, Joseph IB, Menon K
and Frost D: Chemosensitization and radiosensitization of human
lung and colon cancers by antimitotic agent, ABT-751, in athymic
murine xenograft models of subcutaneous tumor growth. Cancer
Chemother Pharmacol. 59:725–732. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hsiao YC, Hsieh YS, Kuo WH, Chiou HL, Yang
SF, Chiang WL and Chu SC: The tumor-growth inhibitory activity of
flavanone and 2’-OH flavanone in vitro and in vivo through
induction of cell cycle arrest and suppression of cyclins and CDKs.
J Biomed Sci. 14:107–119. 2007.PubMed/NCBI
|
|
25.
|
Shyu KG, Huang ST, Kuo HS, Cheng WP and
Lin YL: Antitumor activity of a novel bis-aziridinylnaphthoquinone
(AZ4) mediating cell cycle arrest and apoptosis in non-small cell
lung cancer cell line NCI-H4601. Acta Pharmacol Sin. 28:559–566.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
26.
|
Lee YM, Ting CM, Cheng YK, Fan TP, Wong
RN, Lung ML and Mak NK: Mechanisms of 2-methoxyestradiol-induced
apoptosis and G2/M cell-cycle arrest of nasopharyngeal carcinoma
cells. Cancer Lett. 268:295–307. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27.
|
Zhang HY, Gu YY, Li ZG, Jia YH, Yuan L, Li
SY, An GS, Ni JH and Jia HT: Exposure of human lung cancer cells to
8-chloro-adenosine induces G2/M arrest and mitotic catastrophe.
Neoplasia. 6:802–812. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
28.
|
Chen YL, Lin SZ, Chang JY, Cheng YL, Tsai
NM and Chen SP: In vitro and in vivo studies of a novel potential
anticancer agent of isochaihulactone on human lung cancer A549
cells. Biochem Pharmacol. 72:308–319. 2006. View Article : Google Scholar : PubMed/NCBI
|
